Drug Resistance in Cancer

Drug resistance to cancer treatments is a major concern for patients with the disease. Single and multi-drug resistance to cancer therapeutics can occur, making it difficult to kill the cancer cells. Here is the latest research on drug resistance in cancer.

January 14, 2021
Review
Open Access

The Multifaced Role of STAT3 in Cancer and Its Implication for Anticancer Therapy

International Journal of Molecular Sciences
Manlio Tolomeo, Antonio Cascio
January 13, 2021
Review
Open Access

CD73, Tumor Plasticity and Immune Evasion in Solid Cancers

Cancers
Haitang YangSean R R Hall
January 14, 2021
Review
Open Access

Recent Discoveries of Macromolecule- and Cell-Based Biomarkers and Therapeutic Implications in Breast Cancer

International Journal of Molecular Sciences
Hsing-Ju Wu, Pei-Yi Chu
January 13, 2021
Review
Open Access

Stromal Cells Present in the Melanoma Niche Affect Tumor Invasiveness and Its Resistance to Therapy

International Journal of Molecular Sciences
Justyna MazurkiewiczDorota Nowak
January 15, 2021

Knockdown of cir_RNA PVT1 Elevates Gastric Cancer Cisplatin Sensitivity via Sponging miR-152-3p

The Journal of Surgical Research
Xiaojie WangXiaolei Liu
January 15, 2021
Review

Fasciolosis in India: an overview

Experimental Parasitology
H LalrinkimaM C Lallianchhunga
January 14, 2021
Review
Open Access

Update on the systemic management of radioactive iodine refractory differentiated thyroid cancer (Review)

Molecular and Clinical Oncology
Geethu Babu, Cessal Thommachan Kainickal
January 13, 2021
Open Access

ADMET evaluation in drug discovery. 20. Prediction of breast cancer resistance protein inhibition through machine learning

Journal of Cheminformatics
Dejun JiangTingjun Hou
January 14, 2021

Risk factors for nephrotoxicity associated with polymyxin B therapy in Chinese patients

International Journal of Clinical Pharmacy
Jiali ZhangHaibin Dai
January 14, 2021
Open Access

MITF reprograms the extracellular matrix and focal adhesion in melanoma

ELife
Ramile DilshatEirikur Steingrimsson
January 15, 2021

Adaptive responses to mTOR gene targeting in hematopoietic stem cells reveal a proliferative mechanism evasive to mTOR inhibition

Proceedings of the National Academy of Sciences of the United States of America
Cuiqing FanYi Zheng
January 13, 2021
Open Access

Inhibition of ZEB1-AS1 confers cisplatin sensitivity in breast cancer by promoting microRNA-129-5p-dependent ZEB1 downregulation

Cancer Cell International
Jin GaoSainan Hu
January 15, 2021

Research progress review on long non-coding RNA in colorectal cancer

Neoplasma
JieLing ZhangYiPing Zhu
January 14, 2021

A nanotherapeutic strategy to overcome chemotherapeutic resistance of cancer stem-like cells

Nature Nanotechnology
Shiyang ShenRan Mo

Sign up to follow this feed and discover related papers.

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer Cell Invasion: Nanomedicine

Nanomedicine is a promising alternative for cancer detection and therapy that utilizes nanoparticles, such as liposomes. Nanoparticles can potentially target cancer cell invasion and metastasis. Discover the latest research on Cancer Cell Invasion: Nanomedicine here.

Cancer Disparities

Cancer disparities refers to differences in cancer outcomes (e.g., number of cancer cases, related health complications) across population groups.

Cancer Genomics

Cancer genomics employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research here.

Cancer Immunotherapy

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest research on cancer immunotherapy here.

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

© 2021 Meta ULC. All rights reserved
/feed-previews/drug-resistance-in-cancer/82f7f52e-abb0-4841-85db-8c8a8e28c0c7